Leadership

Management

Ian Estus

President and Chief Executive Officer

Mr. Estus has served as a director on the Board of the Company since August 2016 and as President and Chief Executive Officer since June 2017, and has over 19 years of investment and asset management experience. Prior to joining the Board, Mr. Estus was the Managing Director of Investments of HC2 Holdings, Inc. (NYSE: HCHC), a diversified holding company with investments in various industries including manufacturing, marine services, insurance, utilities, telecommunications and life sciences. Mr. Estus received a B.S. in Business Administration with a Concentration in Accounting from the State University of New York at Buffalo.

Greg Baxter

Executive Chairman of the Board

Mr. Baxter has served as a director on the Board of the Company since October 2015 and Executive Chairman since June 2017, and has over 40 years of financial and operational experience. Mr. Baxter has also served as a director of Turning Point Brands (NYSE: TPB and its predecessor), since April 2006. Mr. Baxter has held senior level positions at Diaz & Altschul Capital Management, SG Cowen, and Rothschild Inc. Mr. Baxter holds a Bachelor of Arts from the University of Victoria in Canada and a Master of Business Administration from the Ivey Business School in London.

Brad Tobin

General Counsel & Secretary

Mr. Tobin joined the Company as the General Counsel in January 2018 with over 10 years of legal and operational experience. Immediately prior to joining the Company, Mr. Tobin served as the General Counsel and Senior Vice President of General Wireless Operations Inc. dba RadioShack where he steered operations and the legal team through two bankruptcies. Preceding this role, Mr. Tobin served on the distressed debt team at Silver Point Capital, LP. Mr. Tobin holds a Juris Doctor from St. John’s University, School of Law in New York and a B.S. in Economics from the University of Wisconsin-Madison.

Board of Directors

Greg Baxter

Executive Chairman

Mr. Baxter has served as a director on the Board of the Company since October 2015 and Executive Chairman since June 2017, and has over 40 years of financial and operational experience. Mr. Baxter has also served as a director of Turning Point Brands (NYSE: TPB and its predecessor), since April 2006. Mr. Baxter has held senior level positions at Diaz & Altschul Capital Management, SG Cowen, and Rothschild Inc. Mr. Baxter holds a Bachelor of Arts from the University of Victoria in Canada and a Master of Business Administration from the Ivey Business School in London.

Ian Estus

Director

Mr. Estus has served as a director on the Board of the Company since August 2016 and as President and Chief Executive Officer since June 2017, and has over 19 years of investment and asset management experience. Prior to joining the Board, Mr. Estus was the Managing Director of Investments of HC2 Holdings, Inc. (NYSE: HCHC), a diversified holding company with investments in various industries including manufacturing, marine services, insurance, utilities, telecommunications and life sciences. Mr. Estus received a B.S. in Business Administration with a Concentration in Accounting from the State University of New York at Buffalo.

David M. Wurzer

Director

David M. Wurzer joined the Company as a director in February 2010. Since 2009, Mr. Wurzer has served as Managing Director, Investments, Senior Managing Director, Investments, and beginning April 2014, as Executive Vice President and Chief Investment Officer at Connecticut Innovations (CI), the State’s “venture capital arm.” He is responsible for oversight of the CI Ventures’ venture capital portfolio and team, as well as sourcing and analyzing investment opportunities, leading CI investments in entrepreneurial high-tech ventures and advising portfolio companies. Prior to joining CI, Mr. Wurzer most recently served as Executive Vice President, Treasurer and Chief Financial Officer of CuraGen Corporation, a biopharmaceutical development company, from September 1997 through December 2007. He has over 30 years of financial experience with growth-oriented companies, including direct involvement with raising capital, strategic transactions and mergers and acquisitions, for both start-up companies and publicly-held entities. Mr. Wurzer serves on the boards of Axerion Therapeutics, Inc., and Thetis Pharmaceuticals, LLC, which are privately held, and on the board Summit Therapeutics plc (NASDAQ: SMMT, LON:SUMM). Mr. Wurzer holds a BBA degree in Accountancy from the University of Notre Dame.

Thomas Helms

Director

Thomas Helms has been a director of Turning Point Brands, Inc. (“Turning Point”) since 1997 and currently serves as the Non-Executive Chairman since May 2016. He served as Executive Chairman from May 2006 to May 2016 and as Non-Executive Chairman from June 1997 to May 2006. He also formerly served as Turning Point’s President. Mr. Helms also formed the predecessor company of Turning Point to aquire certain loose leaf chewing tobacco assets of Lorillard, Inc.

David Glazek

Director

David Glazek brings significant finance and private equity experience to the Board of SDI. Mr. Glazek is a Partner of Standard General, the investment manager of SDI’s largest shareholders, where his responsibilities include investment research and analysis and helping companies with operational, transactional, financing, and legal needs. From 2000-2003 and 2006-2008, he was an investment banker at Lazard Freres & Co., where he focused on mergers and acquisitions and corporate restructurings. He has also worked at the Blackstone Group. Mr. Glazek is currently a Director of Turning Point Brands and Standard Diversified Opportunities, and a Manager of Standard Purification Holdings and Donau Carbon USA. Mr. Glazek holds a J.D. from Columbia Law School and a B.A. from the University of Michigan.

Arnold Zimmerman

Director

Mr. Zimmerman recently joined as a director of our company and is serving as a member of the Audit Committee. Since 2007, he has been President of Catchers Mitt LLC, a marketing consulting company focused on personal care products. From 2002 to 2007, Mr. Zimmerman was the Chairman and CEO of 291 Digital LLC, a graphics imaging and printing company, and from 1999 to 2002 he was Chairman, President and CEO of AM Products Company. He has also held senior executive positions at Revlon-North America and the L’Oreal Retail Hair Products Division from 1967 to 1992. Mr. Zimmerman holds a Bachelor of Arts from the University of Miami. Mr. Zimmerman is a member of the Board of Directors of Turning Point Brands, Inc. (NYSE: TPB), a leading U.S. provider of Other Tobacco Products.